Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. Schembl537014
Molecular Weight | 960.1 g/mol |
---|---|
Molecular Formula | C44H81NO21 |
Hydrogen Bond Donor Count | 12 |
Hydrogen Bond Acceptor Count | 22 |
Rotatable Bond Count | 13 |
Exact Mass | 959.53010859 g/mol |
Monoisotopic Mass | 959.53010859 g/mol |
Topological Polar Surface Area | 353 Ų |
Heavy Atom Count | 66 |
Formal Charge | 0 |
Complexity | 1380 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 22 |
Undefined Atom Stereocenter Count | 1 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 2 |
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
A Erythromycin Gluceptate manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Erythromycin Gluceptate, including repackagers and relabelers. The FDA regulates Erythromycin Gluceptate manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Erythromycin Gluceptate API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Erythromycin Gluceptate supplier is an individual or a company that provides Erythromycin Gluceptate active pharmaceutical ingredient (API) or Erythromycin Gluceptate finished formulations upon request. The Erythromycin Gluceptate suppliers may include Erythromycin Gluceptate API manufacturers, exporters, distributors and traders.
Erythromycin Gluceptate Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Erythromycin Gluceptate GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Erythromycin Gluceptate GMP manufacturer or Erythromycin Gluceptate GMP API supplier for your needs.
A Erythromycin Gluceptate CoA (Certificate of Analysis) is a formal document that attests to Erythromycin Gluceptate's compliance with Erythromycin Gluceptate specifications and serves as a tool for batch-level quality control.
Erythromycin Gluceptate CoA mostly includes findings from lab analyses of a specific batch. For each Erythromycin Gluceptate CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Erythromycin Gluceptate may be tested according to a variety of international standards, such as European Pharmacopoeia (Erythromycin Gluceptate EP), Erythromycin Gluceptate JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Erythromycin Gluceptate USP).
LOOKING FOR A SUPPLIER?